MarketHub

Eubiotics Market Size, Share, Scope, Growth & Forecast Report 2024-2032

Di rockyrai

IMARC Group's report titled "Eubiotics Market Report by Product (Probiotics, Prebiotics, Organic Acids, Essential Oils, and Others), Form (Liquid, Solid), Application (Gut Health, Immunity, Yield, and Others), End Use (Cattle Feed, Poultry Feed, Swine Feed, Aquafeed, and Others), and Region 2024-2032". The global eubiotics market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/eubiotics-market/requestsample Factors Affecting the Growth of the Eubiotics Industry: Regulatory bodies in many countries are implementing stricter guidelines on the use of antibiotics in animal husbandry, aiming to combat antibiotic resistance and promote animal welfare. Governing bodies and international organizations are advocating for the use of natural feed additives that contribute to the health and performance of animals without the negative impacts of antibiotics. These policies encourage the adoption of eubiotics, as they align with efforts to ensure food safety and public health. Furthermore, the emphasis on animal welfare and the ethical treatment of livestock is leading to more natural and humane approaches to animal farming. Eubiotics play a crucial role in this paradigm shift, offering a sustainable and welfare-friendly alternative to conventional growth promoters. Scientific advances in understanding the complex interactions within the gut microbiota of animals are highlighting the importance of maintaining a healthy microbial balance for optimal animal health and productivity. Eubiotics offer a targeted approach by modulating the gut microbiome to enhance nutrient absorption, strengthen the immune system, and prevent gastrointestinal disorders. This growing body of research supports the development of more effective and tailored eubiotic products. Additionally, the focus on precision animal nutrition, where feed is customized to the specific needs of each animal, relies heavily on the insights provided by microbiome research, creating new opportunities for the application of eubiotics. Innovations in encapsulation technologies are improving the stability and efficacy of eubiotics, ensuring that these beneficial compounds reach the gut of the animal intact and are released in a controlled manner. This enhances the appeal of eubiotics to livestock producers by making them more cost-effective and efficient. In addition, the development of sophisticated blending and dosing equipment allows for more precise inclusion of eubiotics in feed, optimizing their beneficial effects. These technological advancements not only improve the performance of eubiotics but also expand their potential applications across different types of animal feed. Leading Companies Operating in the Global Eubiotics Industry: Eubiotics Market Report Segmentation: By Product: Probiotics exhibit a clear dominance in the market due to their well-documented benefits in improving animal gut health, immunity, and overall productivity. By Form: Solid represents the largest segment attributed to its ease of storage, stability, and convenience in mixing with animal feed. By Application: Gut health holds the biggest market share, as maintaining a healthy gut is essential for optimal nutrient absorption, immunity, and overall health in animals. By End Use: Poultry feed accounts for the majority of the market share, driven by the growing demand for poultry meat and eggs, necessitating efficient and healthy feed additives. Regional Insights: Europe dominates the market owing to the implementation of strict animal welfare regulations, rising focus on sustainable livestock production, and the increasing preference for antibiotic-free meat and dairy products. Global Eubiotics Market Trends: The growing development of customized eubiotic solutions tailored to specific animal species, age groups, and health conditions is offering a favorable market outlook. This customization is facilitated by advancements in genomics and metabolomics, allowing for a deeper understanding of the specific nutritional and health needs of different animals. Additionally, the integration of digital tools, such as precision feeding systems and health monitoring wearables, offers the potential to optimize the use of eubiotics in real time, enhancing their effectiveness and efficiency. These technologies can monitor the health status and nutritional needs of individual animals or herds, enabling precise adjustments to their diet, including the optimal inclusion of eubiotics. Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization. About Us: IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise. Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations. Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-631-791-1145